There are several dozen single-nucleotide polymorphisms (SNPs), which have been identified mainly by the efforts of the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) as potential contributors to BC risk in BRCA1/2 mutation carriers [8,9,10,11]. The gene discussed is BRCA1; the disease is breast cancer.